PHOSIMER (Osimertinib) 80mg*30 | Pharma 2 Laos Generic | GLT

Generic Information: PHOSIMER (Osimertinib) 80mg — Laos

PHOSIMER is the osimertinib generic produced by Pharma 2 Vientiane, also known as National Pharmaceutical Factory No. 2 of Laos — a long-established state-linked manufacturer under the Lao Ministry of Health. The product is supplied as 80 mg film-coated tablets in 30-tablet packs. Pharma 2 Vientiane is one of the most comprehensive drug producers in Laos, with a broad portfolio spanning oral solids, injectables and infusions, and it manufactures PHOSIMER under Lao GMP standards.

Because Pharma 2 Vientiane is a well-known domestic institution, PHOSIMER carries a level of local traceability that some buyers value. As with all generics, the active ingredient — osimertinib — and the 80 mg dose are the key verification points.

What Is PHOSIMER Used For?

PHOSIMER treats EGFR mutation-positive non-small cell lung cancer. It is used first-line for advanced EGFR-mutant disease, as adjuvant therapy after surgery in eligible early-stage patients, and for T790M-positive disease after progression on a prior EGFR TKI. Its penetration into the central nervous system makes it useful when brain metastases are present.

How Does PHOSIMER Work?

The osimertinib in PHOSIMER irreversibly inhibits mutated EGFR, targeting exon 19 deletions, L858R mutations and the T790M resistance mutation while sparing wild-type EGFR. This mutant-selective blockade is the basis of its effectiveness across treatment lines and its relatively tolerable side-effect profile.

Indications

• First-line advanced EGFR-mutant NSCLC.
• Adjuvant therapy after resection of EGFR-mutant NSCLC.
• T790M-positive NSCLC after prior EGFR-TKI therapy.

Dosage and Administration

PHOSIMER is taken as one 80 mg tablet once daily, with or without food, swallowed whole. Missed doses beyond 12 hours are skipped. The dose can be reduced to 40 mg daily for side-effect management, and treatment continues until progression or unacceptable toxicity.

Side Effects

Common adverse events include diarrhoea, rash, dry skin, nail changes, stomatitis and fatigue. Rare but serious risks such as interstitial lung disease, QT prolongation and cardiomyopathy warrant monitoring; new respiratory symptoms or palpitations should be reported immediately.

Storage

Store PHOSIMER below 30°C, in a dry place, in the original container and away from children. Use before the expiry date.

Why Choose the GLT?

GLT verifies PHOSIMER batches against Pharma 2 Vientiane's documentation and provides a transparent Lao supply route. Lao generics of osimertinib are typically several times cheaper than branded Tagrisso in Western markets, making long-term EGFR-targeted therapy far more sustainable. We support both patient and institutional orders with clear documentation and direct support.

How to Order PHOSIMER from GLT

To order PHOSIMER 80 mg (30 tablets), message GLT on WhatsApp at +86 15234153837 or email [email protected]. Provide your quantity, destination country and order type, and we will confirm availability, batch details and shipping terms.

FAQ

Who makes PHOSIMER? PHOSIMER is manufactured by Pharma 2 Vientiane (National Pharmaceutical Factory No. 2 of Laos).

Is PHOSIMER the same as Tagrisso? PHOSIMER contains the same active ingredient (osimertinib) at the same 80 mg dose as Tagrisso.

Can I buy PHOSIMER online? Yes, GLT supplies PHOSIMER internationally; contact us on WhatsApp or email.